A novel bivalent ligand that contains two distinct pharmacophores linked through a spacer, one of which will interact with the mu opioid receptor (MOR) and the other with CXCr4. Naltrexone and It1t were selected as the pharmacophores to generate the bivalent probe.
Please note we may take up to three days to respond to your enquiry.
CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.